Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)

HKG:2526 Revenue

In the year 2025, Hangzhou Diagens Biotechnology had annual revenue of 164.42M CNY with 133.72% growth. Hangzhou Diagens Biotechnology had revenue of 52.81M in the quarter ending December 31, 2025.

• Revenue: 164.42M CNY
• Revenue Growth: +133.72%
• P/S Ratio: 150.39
• Revenue / Employee: 990.51K CNY
• Employees: 166
• Market Cap: 27.52B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	164.42M	94.07M	133.72%
Dec 31, 2024	70.35M	17.51M	33.13%
Dec 31, 2023	52.84M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error